REGENXBIO Inc. Files 8-K: Regulation FD Disclosure & Other Events
Ticker: RGNX · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1590877
Sentiment: neutral
Topics: disclosure, regulation-fd, financials
TL;DR
REGENXBIO filed an 8-K on March 3rd covering Reg FD disclosures and other events.
AI Summary
On March 3, 2025, REGENXBIO Inc. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The filing also includes financial statements and exhibits. The company's principal executive offices are located at 9804 Medical Center Drive, Rockville, Maryland.
Why It Matters
This 8-K filing provides important updates and disclosures for REGENXBIO Inc. investors, including regulatory information and financial statements.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant negative news or events.
Key Numbers
- 20850 — ZIP Code (Principal Executive Offices)
Key Players & Entities
- REGENXBIO Inc. (company) — Registrant
- March 3, 2025 (date) — Date of earliest event reported
- 9804 Medical Center Drive, Rockville, Maryland (location) — Principal Executive Offices
- 001-37553 (other) — SEC File Number
FAQ
What specific events are covered under the 'Other Events' section of this 8-K filing?
The provided text does not specify the details of the 'Other Events' beyond listing it as an item in the filing.
What is the nature of the 'Regulation FD Disclosure' mentioned in the filing?
The filing indicates a 'Regulation FD Disclosure' as an item, but the specific content of this disclosure is not detailed in the provided text.
When was REGENXBIO Inc. incorporated, and in which jurisdiction?
REGENXBIO Inc. was incorporated in Delaware, as stated in the filing.
What is the IRS Employer Identification Number for REGENXBIO Inc.?
The IRS Employer Identification Number for REGENXBIO Inc. is 47-1851754.
What is the SIC code for REGENXBIO Inc.?
The Standard Industrial Classification (SIC) code for REGENXBIO Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding REGENXBIO Inc. (RGNX).